Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Moxonidine Hydrochloride Tablets

Approval Number

国药准字H20041250

Company精华制药集团股份有限公司

Registration Date

August 21, 2020

Drug Information

Generic Name

盐酸莫索尼定片

Dosage Form

片剂

Strength

0.2mg(按C9H12ClN5O计算)

Drug Type

化学药品

Registration Date

August 21, 2020

Company Information

Applicant Company

Company Name精华制药集团股份有限公司

Manufacturing Company

Company Name精华制药集团股份有限公司

Company Address

江苏省南通市港闸经济开发区兴泰路9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy